Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study

BACKGROUND: The concurrent chemoradiotherapy for cervical cancer treatment is well accepted since 1999. This randomized, phase III trial aimed to observe if any improved outcome could be obtained capitalizing on the synergistic activity of gemcitabine, cisplatin, XRT. MATERIALS AND METHODS: Stage II...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Sanjoy, Devleena, Maji, Tapas, Chaudhuri, Prabir, Lahiri, Debarshi, Biswas, Jaydip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342718/
https://www.ncbi.nlm.nih.gov/pubmed/22557778
http://dx.doi.org/10.4103/0971-5851.92809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342718/
https://www.ncbi.nlm.nih.gov/pubmed/22557778
http://dx.doi.org/10.4103/0971-5851.92809

Ejemplares similares